Permanent neonatal diabetes due to a novel insulin signal peptide mutation

Pediatric Diabetes

Volumn 14, Issue 4, 2013, Pages 299-303

  Hussain, Suhaimi ^a   Mohd Ali, Johari ^b   Jalaludin, Muhammad Yazid ^b   Harun, Fatimah ^b  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Congenital absence of insulin producing cells with diabetes mellitus; Insulin; Mutation; Proinsulin; Signal peptide

Indexed keywords

GLUCOSE; INSULIN; INSULIN ASPART; ISOPHANE INSULIN; SIGNAL PEPTIDE;

ARTICLE; CASE REPORT; CONTINUOUS INFUSION; DIABETES CONTROL; DIABETIC KETOACIDOSIS; DRUG DOSE INCREASE; ENTERIC FEEDING; FEMALE; FOLLOW UP; GENE MUTATION; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPOGLYCEMIA; LOW BIRTH WEIGHT; NEWBORN; NEWBORN DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT REFUSAL;

CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INSULIN; INSULIN, ISOPHANE; INSULIN, REGULAR, HUMAN; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN PRECURSORS; PROTEIN SORTING SIGNALS;

EID: 84878223129     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12011     Document Type: Article

References (27)

1. Iafusco D, Massa O, Pasquino B et al. Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90, 000 live births. Acta Diabetol 2012: 49: 405-408.
2. Temple IK, Gardner RJ, Mackay DJ, Barber JC, Robinson DO, Shield JP. Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes. Diabetes 2000: 49: 1359-1366.
3. Glaser B. Insulin mutations in diabetes: the clinical spectrum. Diabetes 2008: 57: 799-800.
4. Stoy J, Edghill EL, Flanagan SE et al. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci USA 2007: 104: 15040-15044.
5. Edghill EL, Flanagan SE, Patch AM et al. Insulin mutation screening in 1, 044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008: 57: 1034-1042.
6. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005: 54: 2503-2513.
7. Babenko AP, Polak M, Cave H et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 2006: 355: 456-466.
8. Stoy J, Steiner DF, Park SY, Ye H, Philipson LH, Bell GI. Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocr Metab Disord 2010: 11: 205-215.
9. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997: 15: 106-110.
10. Njolstad PR, Sovik O, Cuesta-Munoz A et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med 2001: 344: 1588-1592.
11. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000: 25: 406-409.
12. Wildin RS, Ramsdell F, Peake J et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001: 27: 18-20.
13. Liu M, Haataja L, Wright J et al. Mutant INS-gene induced diabetes of youth: proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport. PLoS One 2010: 5: e13333.
14. Meur G, Simon A, Harun N et al. Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention. Diabetes 2010: 59: 653-661.
15. Rajan S, Eames SC, Park SY et al. In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes. Am J Physiol Endocrinol Metab 2010: 298: E403-E410.
16. Polak M, Dechaume A, Cave H et al. Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group. Diabetes 2008: 57: 1115-1119.
17. Petersen TN, Brunak S, von Heijne G, Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 2011: 8: 785-786.
18. Cioffi JA, Allen KL, Lively MO, Kemper B. Parallel effects of signal peptide hydrophobic core modifications on co-translational translocation and post-translational cleavage by purified signal peptidase. J Biol Chem 1989: 264: 15052-15058.
19. Flanagan SE, Patch AM, Ellard S. Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomarkers 2010: 14: 533-537.
20. von Heijne G. Signal sequences. The limits of variation. J Mol Biol 1985: 184: 99-105.
21. Bankaitis VA, Rasmussen BA, Bassford PJ Jr. Intragenic suppressor mutations that restore export of maltose binding protein with a truncated signal peptide. Cell 1984: 37: 243-252.
22. Hatsuzawa K, Tagaya M, Mizushima S. The hydrophobic region of signal peptides is a determinant for SRP recognition and protein translocation across the ER membrane. J Biochem 1997: 121: 270-277.
23. Fikes JD, Bankaitis VA, Ryan JP, Bassford PJ Jr. Mutational alterations affecting the export competence of a truncated but fully functional maltose-binding protein signal peptide. J Bacteriol 1987: 169: 2345-2351.
24. Kendall DA, Doud SK, Kaiser ET. A comparative analysis of single- and multiple-residue substitutions in the alkaline phosphatase signal peptide. Biopolymers 1990: 29: 139-147.
25. Symoens S, Malfait F, Renard M et al. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome. Hum Mutat 2009: 30: E395-E403.
26. Seppen J, Steenken E, Lindhout D, Bosma PJ, Elferink RP. A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II. FEBS Lett 1996: 390: 294-298.
27. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 1982: 157: 105-132.